Background {#Sec1}
==========

Coagulase-negative *Staphylococci* (CoNS) are considered as a major cause of bloodstream infections (BSIs) in intensive care units (ICUs) patients \[[@CR1]\]. Glycopeptides especially vancomycin are frequently considered as the first choice for treatment of serious infections caused by CoNS due to rise in resistance to Beta lactam antibiotics \[[@CR2]\].

Although, glycopeptides resistance in CoNS has been first detected in 1987 \[[@CR3]\]. The increased use of glycopeptides leads to diminished glycopeptides susceptibility among CoNS \[[@CR4]\]. Later, another type of resistance named heteroresistance has been also described in clinical CoNS isolates in which vancomycin-intermediate subpopulation of cells exist in susceptible microbial population \[[@CR5], [@CR6]\].

Although, there is decrease susceptibility to glycopeptides in CoNS \[[@CR6], [@CR7]\], little studies were conducted on heteroresistance to glycopeptides in CoNS in comparison to *S. aureus* \[[@CR8]--[@CR10]\]. The objective of the present study was to determine the prevalence of heteroresistance vancomycin coagulase negative *Staphylococci* among patients with BSIs in ICUs of Mansoura university hospitals.

Patients and methods {#Sec2}
====================

This study was conducted on patients who had BSI in the ICUs of Mansoura university hospitals from January 2014 to March 2016. Nine ICUs were included in this study; five medical and four surgical ICUs. Blood samples were collected from patients admitted to these ICUs and presented with symptoms with suspected bloodstream infections according to CDC criteria \[[@CR11]\]. Blood stream infections caused by CoNS are considered only if at least two blood cultures positive for CoNS were collected within 5 days \[[@CR12]\]. *Staphylococci* were identified by standard microbiological methods \[[@CR13]\]. CONS was confirmed by negative coagulase (*coa*) gene \[[@CR14]\]. Identification of Species was done by API Staph 32 (bioMérieux) according to the manufacture instructions.

The data including: sex, age, clinical diagnosis and systemic antimicrobial therapy were retrieved from the medical records.

Oxacillin susceptibility testing {#Sec3}
--------------------------------

Resistance to oxacillin was evaluated by cefoxitin (30 µg) (Mast Diagnostics, Merseyside-UK) disc diffusion method according to the Clinical and Laboratory Standards Institute (CLSI) criteria \[[@CR15]\]. Oxacillin resistant CoNS isolates were tested for the presence of *mecA* gene. The PCR for *mecA* gene was done as previously described \[[@CR16]\].

Vancomycin susceptibility testing {#Sec4}
---------------------------------

Agar dilution method was done to determine the vancomycin susceptibility according to CLSI guidelines \[[@CR15]\]. Standard vancomycin susceptible *S. aureus* ATCC 29213 was included as quality control.

Isolated strains were evaluated for vancomycin heteroresistance using the brain heart infusion (BHI) screen agar method as formerly described \[[@CR17]\]. Briefly, bacterial suspension of 0.5 McFarland turbidity was prepared from an overnight culture on blood agar plate. Four 10-µL drops of the suspension were dropped onto a BHI agar plate (Mast Diagnostics, Merseyside-UK) containing 4 µg/mL vancomycin (Sigma Chemical Co., St. Louis, Mo.). Plates were incubated at 35 °C ± 2 for 48 h; the number of colonies in each drop was counted. A strain was considered to be heteroresistant to vancomycin if ≥ 1 droplet had ≥ 2 colonies.

Population analysis profile (PAP) for vancomycin heteroresistance {#Sec5}
-----------------------------------------------------------------

The PAP method was used to confirm vancomycin heteroresistance in subpopulations. All isolates that grown on BHI screen agar plate were included in PAP experiments \[[@CR18]\]. Inoculums of (100 μL) 0.5 McFarland turbidity bacterial suspension and serial tenfold dilutions were cultured on BHI agar plates containing vancomycin at the concentrations 2, 4, 6, 8, 10, 12, 14 and 16 μg/mL at 35 °C. After 48 h, the number of colonies on plate in each concentration of drug was counted. Each strain was tested twice.

Heteroresistant strain was defined as any CoNS strain that has a susceptible vancomycin MIC by agar dilution method, can grow on BHI with 4 µg/mL vancomycin and has by PAP susceptibility testing a MIC greater than or equal to 8 µg/mL in the two experiments \[[@CR19]\].

Results {#Sec6}
=======

Total of 743 of clinically suspected blood stream infections were involved in this study. Fifty-eight isolates of CoNS were detected by absence of *coA* gene. *S. epidermidis* was the most common isolated species. Distribution of CoNS was summarized in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Distribution of CoNS species

Resistance rates of the isolated CoNS to oxacillin were reported to be 76.6% (36/47). All isolates were categorized as vancomycin susceptible using agar dilution method according to the CLSI guidelines \[[@CR15]\]. The MICs of vancomycin range from 0.25 to 2 and 0.25 to 1 µg/mL in oxacillin resistant and oxacillin sensitive isolates respectively. Vancomycin MICs by agar dilution method among different CoNS species are shown in Table [1](#Tab1){ref-type="table"}.Table 1Vancomycin MICs by agar dilution and species distribution of 58 CoNS strains isolated from blood stream infectionsCoNS speciesVancomycin MICs μg/ml0.250.51248Oxacillin resistant isolates1121714----*S. epidermidis*--7109----*S. capitis*1234----*S. haemolyticus*--23------*S. lugdunesis*------1----Unidentified species--11------Oxacillin sensitive isolates644------*S. epidermidis*421------*S. capitis*11--------*S. haemolyticus*11--------*S. lugdunesis*----2------Unidentified species----1------Total7162114----

Nine of these CoNS isolates can grow on the BHI agar containing 4 μg/mL of vancomycin. vancomycin MICs ranged from (1--2 µg/mL) by agar dilution method. By PAP these nine isolates were in the vancomycin intermediate susceptibility zone ranging from 10 to 16 µg/mL. All these heteroresistant isolates were oxacillin resistant. Majority of heteroresistant strains were *S. epidermidis* (66.7%). The PAPs of these nine strains are shown in Fig. [2](#Fig2){ref-type="fig"}.Fig. 2PAP analysis of nine strains can grow on BHI with 4 µg/mL Vancomycin

Most of heteroresistant isolates were isolated from patients with previous vancomycin exposure (6/9). The characteristics of the vancomycin heteroresistant CoNS isolates and Characteristics of patients are shown in Table [2](#Tab2){ref-type="table"}.Table 2Characteristics of Vancomycin heteroresistant CoNS isolates and patients featuresStrain No*Staphylococus* speciesOXVA MICPAP MICAge (yrs)SexICUUnderlying diseaseVA exposure14*S. epidermidis*R21668MMICUHypertensive encephalopathyYes40*S. epidermidis*R21259MMICULiver cirrhosisNO52*S. epidermidis*R11462FMICUPneumoniaYes31*S. epidermidis*R21266MSICUCancer colonNo41*S. epidermidis*R11038FSICUMotor car accidentYes21*S. epidermidis*R21025MSICUMotor car accidentYes51*S capitis*R21456MSICULiver recipientYes4*S. capitis*R21467FMICUCerebral strokeYes18*S. haemolyticus*R41269MMICUDiabetic ketoacidosisNo*R* resistant, *Va* vancomycin, *SICU* surgical ICU, *MICU* medical ICU, *M* male, *F* female

Discussion {#Sec7}
==========

Coagulase-negative *Staphylococci* were considered as contaminants of bacterial cultures. However, this group especially *S. epidermidis* has emerged as an important pathogen and a major cause of serious infections in ICU patients \[[@CR1], [@CR20]\]. In this study, *S. epidermidis* was the most common isolated member of CoNS followed by *S. capitis*. This was in agreement with prior reports conducted in adult ICUs \[[@CR5], [@CR20]\].

In the current study, resistance of CoNS to oxacillin was 76.6%. Our study supports previous reports that show increased resistance of CoNS to oxacillin in which oxacillin resistance among CoNS reached 82.4% \[[@CR21]\]. Owing to increased resistance to methicillin among CoNS, vancomycin is frequently considered as the first choice in antimicrobial therapy \[[@CR22]\]. In contrast to oxacillin, all CoNS isolates in the present study were sensitive to vancomycin. This was in agreement with other studies conducted on different samples demonstrated that all isolates of CoNS were sensitive to vancomycin \[[@CR23]--[@CR25]\]. Vancomycin resistance is still infrequent in CoNS. However, heterogeneous resistance was reported among CoNS and was associated with failure of vancomycin therapy. These heteroresistant microcolonies may be a precursor of vancomycin resistance \[[@CR5], [@CR6]\]. These heterogeneous resistant strains have a susceptible vancomycin MIC, but they can grow in presence of 4 µg/mL vancomycin which is greater than their MIC \[[@CR19]\].

Despite the presence of many methods for diagnosis of vancomycin heteroresistance in *Staphylococci* as modified E test, PAP, PAP-AUC and disc diffusion method \[[@CR26]--[@CR28]\], still PAP method is the most reliable method and considered as the gold standard for the detection of heteroresistant *Staphylococci* \[[@CR29]\]. In the present study, nine isolates (15.5%) showed vancomycin heteroresistance profile identified by growth on BHI containing 4 µg/mL vancomycin and confirmed by PAP. The prevalence of heteroresistance was similar to previous reports that range from (7.4 to 18.3%) \[[@CR28], [@CR21]\]. All heteroresistant isolates were oxacillin resistant and most of them were associated previous vancomycin therapy. In spite of susceptibility of all isolates to vancomycin, there was an increase in vancomycin MIC range of oxacillin resistant isolates (.25--2 µg/mL) towards the intermediate cutoff. In prior studies, increase in vancomycin MIC and rise of heteroresistant *Staphylococci* among BSI was attributed to previous use of β lactams or glycopeptides, patients admission to ICU and high rate of oxacillin resistance \[[@CR28], [@CR4]\]. Many previous reports show the possible relation of reduced susceptibility to glycopeptides and methicillin resistant CoNS isolates \[[@CR30]\]. More studies extending longer durations are needed to investigate if there is a gradual increase in vancomcin MICs in oxacillin resistant CoNS like vancomycin MICs creep in methicillin resistant *S. aureus*.

Conclusion {#Sec8}
==========

This study alerts about the emergence of oxacillin-resistant CoNS showed heteroresistance to vancomycin. These heteroresistance strains were susceptible to vancomycin and cannot be detected by conventional standard methods. This implies the need of screening test for heteroresistance to avoid therapeutic failure. So, we should be aware of the potential reduction in vancomycin susceptibility of this pathogen, and this should be considered in determination of both empirical and rational therapy.
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